|
|
| Zeile 5: |
Zeile 5: |
| | | | |
| | *'''[[Reviews on covid19 disease]]''' | | *'''[[Reviews on covid19 disease]]''' |
| − | {{tp|p=32020915|t=2020. The Novel Coronavirus: A Bird s Eye View |pdf=|usr=}}
| |
| − | {{tp|p=32112977|t=2020. World Health Organization declares global emergency: A review of the 2019 novel coronavirus (COVID-19) |pdf=|usr=}}
| |
| − | {{tp|p=32125458|t=ä. COVID-19: a novel coronavirus and a novel challenge for critical care |pdf=|usr=}}
| |
| − | {{tp|p=32257431|t=2020. COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses |pdf=|usr=}}
| |
| − | {{tp|p=32201335|t=2020. Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID-19 Pandemic |pdf=|usr=}}
| |
| | | | |
| | ---- | | ---- |
| Zeile 68: |
Zeile 63: |
| | | | |
| | *'''[[Dermatology]]''' | | *'''[[Dermatology]]''' |
| − | {{tp|p=32213305|t=2020. COVID-19 can present with a rash and be mistaken for dengue |pdf=|usr=}}
| |
| − | {{tp|p=32339706|t=ä. Cutaneous manifestations in COVID-19: Lessons learned from current evidence |pdf=|usr=}}
| |
| − | {{tp|p=32339703|t=ä. Characterization of acute acro-ischemic lesions in non-hospitalized patients: a case series of 132 patients during the COVID-19 outbreak |pdf=|usr=}}
| |
| − | {{tp|p=32305439|t=ä. Varicella-like exanthem as a specific COVID-19-associated skin manifestation: multicenter case series of 22 patients |pdf=|usr=}}
| |
| − | {{tp|p=32283229|t=ä. A dermatologic manifestation of COVID-19: Transient livedo reticularis |pdf=|usr=}}
| |
| − |
| |
| | | | |
| | *'''[[Gastroenterology, hepatology]]''' | | *'''[[Gastroenterology, hepatology]]''' |
| Zeile 98: |
Zeile 87: |
| | | | |
| | *'''[[Diagnosis (Lung CT, Sonography)]]''' | | *'''[[Diagnosis (Lung CT, Sonography)]]''' |
| − | {{tp|p=32091414|t=2020. Chest CT Findings in Patients With Coronavirus Disease 2019 and Its Relationship With Clinical Features |pdf=|usr=}}
| |
| − | {{tp|p=32134800|t=2020. Clinical and High-Resolution CT Features of the COVID-19 Infection: Comparison of the Initial and Follow-up Changes |pdf=|usr=}}
| |
| − | {{tp|p=32118615|t=2020. The Clinical and Chest CT Features Associated With Severe and Critical COVID-19 Pneumonia |pdf=|usr=}}
| |
| − | {{tp|p=32304402|t=2020. The performance of chest CT in evaluating the clinical severity of COVID-19 pneumonia: identifying critical cases based on CT characteristics |pdf=|usr=}}
| |
| − | {{tp|p=32286021|t=2020. Imaging Findings in Four COVID-19 Patients |pdf=|usr=}}
| |
| − |
| |
| | | | |
| | *'''[[Diagnosis (other modalities)]]''' | | *'''[[Diagnosis (other modalities)]]''' |
| Zeile 121: |
Zeile 104: |
| | | | |
| | *'''[[Risk and special populations]]''' | | *'''[[Risk and special populations]]''' |
| − | {{tp|p=32355869|t=ä. The Dermatologist?s Perspective: Why is COVID-19 mortality lower in females than males?|pdf=|usr=}}
| |
| − | {{tp|p=32222883|t=ä. Chronic kidney disease is associated with severe coronavirus disease 2019 (COVID-19) infection |pdf=|usr=}}
| |
| − | {{tp|p=32125452|t=ä. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China |pdf=|usr=}}
| |
| − | {{tp|p=32297089|t=ä. Switch from oral anticoagulants to parenteral heparin in SARS-CoV-2 hospitalized patients |pdf=|usr=}}
| |
| − | {{tp|p=32361701|t=2020. COVID-19 Rapid Guideline in Kidney Transplant Recipients |pdf=|usr=}}
| |
| − | {{tp|p=32349772|t=2020. Novel Coronavirus disease (COVID-19) in newborns and infants: what we know so far |pdf=|usr=}}
| |
| − | {{tp|p=32333915|t=ä. Association of Respiratory Allergy, Asthma and Expression of the SARS-CoV-2 Receptor, ACE2 |pdf=|usr=}}
| |
| − | {{tp|p=C7152876|t=ä. Risk factors for severity and mortality in adult COVID-19 inpatients in Wuhan |pdf=|usr=}}
| |
| − | {{tp|p=32371047|t=ä. Changes in medication adherence among patients with asthma and COPD during the COVID-19 pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32344190|t=ä. Debate on Drugs That May Aggravate COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32224277|t=2020. COVID-19 and immunomodulator/immunosuppressant use in dermatology |pdf=|usr=}}
| |
| − | {{tp|p=32199889|t=2020. Should biologics for psoriasis be interrupted in the era of COVID-19?|pdf=|usr=}}
| |
| − | {{tp|p=32283234|t=ä. Biologics for psoriasis during COVID-19 outbreak |pdf=|usr=}}
| |
| − | {{tp|p=32246966|t=ä. COVID-19, syphilis and biologic therapies for psoriasis and psoriatic arthritis: A word of caution |pdf=|usr=}}
| |
| − | {{tp|p=C7160444|t=ä. Use of systemic immunomodulatory therapies during the coronavirus disease 2019 (COVID-19) pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32330632|t=ä. Risk of hospitalization and death from COVID-19 infection in patients with chronic plaque psoriasis receiving a biological treatment and renal transplanted recipients in maintenance immunosuppressive treatment |pdf=|usr=}}
| |
| − | {{tp|p=32305444|t=ä. COVID-19 and racial disparities |pdf=|usr=}}
| |
| − | {{tp|p=32283235|t=ä. Various forms of skin rash in COVID-19 : a reply |pdf=|usr=}}
| |
| − | {{tp|p=32283233|t=ä. Reply to ?COVID-19 can present with a rash and be mistaken for Dengue?: Petechial rash in a patient with COVID-19 infection |pdf=|usr=}}
| |
| − |
| |
| | | | |
| | *'''[[The morbid survivor]]''' | | *'''[[The morbid survivor]]''' |
| Zeile 167: |
Zeile 130: |
| | | | |
| | *'''[[Candidate Compounds Covid19]]''' | | *'''[[Candidate Compounds Covid19]]''' |
| − | {{tp|p=32368489|t=2020. The pathogenesis and alternative treatment of SARS-CoV2 |pdf=|usr=}}
| |
| − | {{tp|p=32289016|t=2020. Herbal medicine and pattern identification for treating COVID-19: a rapid review of guidelines |pdf=|usr=}}
| |
| − | {{tp|p=32125455|t=ä. Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target |pdf=|usr=}}
| |
| − | {{tp|p=32347443|t=ä. Camostat mesilate therapy for COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32333086|t=ä. Remdesivir bei Patienten mit schwerer COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32378817|t=2020. Inhaled Nebulized Sodium Pyruvate Use in COVID-19 Patients |pdf=|usr=}}
| |
| − | *[https://www.nature.com/articles/d41573-020-00073-5 Nature: The COVID-19 vaccine development landscape]
| |
| − | {{tp|p=32283237|t=ä. Hydroxychloroquine and ivermectin: a synergistic combination for COVID-19 chemoprophylaxis and/or treatment?|pdf=|usr=}}
| |
| − | {{tp|p=32278797|t=ä. The use of Janus kinase inhibitors in the time of SARS-CoV-2 |pdf=|usr=}}
| |
| − | {{tp|p=32348818|t=ä. Risks of Hydroxychloroquine use for COVID-19 prophylaxis |pdf=|usr=}}
| |
| − | {{tp|p=32339701|t=ä. Potential role of Janus kinase inhibitors in COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32344070|t=ä. Calm before the storm: understanding the role of JAK inhibitors in COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32283236|t=ä. Does hydroxychloroquine combat COVID-19? A timeline of evidence |pdf=|usr=}}
| |
| − |
| |
| | | | |
| | | | |
| Zeile 203: |
Zeile 152: |
| | | | |
| | *'''[[Passive protective equipment]]''' | | *'''[[Passive protective equipment]]''' |
| − | {{tp|p=32325718|t=2020. Personal Safety during the COVID-19 Pandemic: Realities and Perspectives of Healthcare Workers in Latin America |pdf=|usr=}}
| |
| − | {{tp|p=32334119|t=ä. Addressing the corona virus outbreak: will a novel filtered eye mask help?|pdf=|usr=}}
| |
| − | {{tp|p=32203757|t=2020. Policies on the use of respiratory protection for hospital health workers to protect from coronavirus disease (COVID-19) |pdf=|usr=}}
| |
| − | {{tp|p=32265088|t=ä. Custom-made 3D-printed face masks in case of pandemic crisis situations with a lack of commercially available FFP2/3 masks |pdf=|usr=}}
| |
| − | {{tp|p=32171808|t=2020. Skin damage among health care workers managing coronavirus disease-2019 |pdf=|usr=}}
| |
| − | {{tp|p=32171807|t=2020. Occupational skin disease among health care workers during the coronavirus (COVID-19) epidemic |pdf=|usr=}}
| |
| − | {{tp|p=32171806|t=2020. Behavioral considerations and impact on personal protective equipment use: Early lessons from the coronavirus (COVID-19) pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32268168|t=ä. Rational hand hygiene during COVID-19 pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32360755|t=ä. A ?paper diaper? in N95 respirator |pdf=|usr=}}
| |
| − | {{tp|p=32348829|t=ä. Proposed approach for reusing surgical masks in COVID-19 pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32330629|t=ä. Personal Protective Equipment Recommendations Based on COVID-19 Route of Transmission |pdf=|usr=}}
| |
| − | {{tp|p=32305441|t=ä. Overzealous hand hygiene during the COVID 19 pandemic causing an increased incidence of hand eczema among general population |pdf=|usr=}}
| |
| − |
| |
| − |
| |
| | | | |
| | *'''[[Running your hospital]]''' | | *'''[[Running your hospital]]''' |
| − | {{tp|p=32289019|t=2020. The COVID-19 pandemic: The ?black swan? for mental health care and a turning point for e-health |pdf=|usr=}}
| |
| − | {{tp|p=32339137|t=2020. Mental health and a novel coronavirus (2019-nCoV) in China |pdf=|usr=}}
| |
| − | {{tp|p=32243877|t=2020. Running a virtual allergy division and training program in the time of COVID-19 pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32317114|t=ä. An academic allergy unit during COVID-19 pandemic in Italy |pdf=|usr=}}
| |
| − | {{tp|p=32224232|t=ä. COVID-19: Pandemic Contingency Planning for the Allergy and Immunology Clinic |pdf=|usr=}}
| |
| − | {{tp|p=32220575|t=ä. Telemedicine in the Era of COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32278865|t=ä. Health-Related Quality of Life in Common Variable Immunodeficiency Italian Patients Switched to Remote Assistance During the COVID-19 Pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32315792|t=ä. Acute At Home Management of Anaphylaxis During The Covid-19 Pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32304834|t=ä. Risk Communication During COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32224276|t=2020. Ethical outpatient dermatology care during the coronavirus (COVID-19) pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32213307|t=2020. Dermatology practices as vectors for COVID-19 transmission: A call for immediate cessation of nonemergent dermatology visits |pdf=|usr=}}
| |
| − | {{tp|p=32283243|t=ä. Treatment considerations for patients with pemphigus during the COVID-19 pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32283238|t=2020. Optimizing teledermatology visits for dermatology resident education during the COVID-19 pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32277972|t=ä. Strategic dermatology clinical operations during the coronavirus disease 2019 (COVID-19) pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32259536|t=ä. Dermatology residents and the care of patients with coronavirus disease 2019 (COVID-19) |pdf=|usr=}}
| |
| − | {{tp|p=32339708|t=ä. Telemedicine for Inpatient Dermatology Consultations in Response to the COVID-19 Pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32348822|t=ä. What matters most: Why the COVID-19 pandemic should prompt us to revisit the dermatology resident selection process |pdf=|usr=}}
| |
| − | {{tp|p=32339700|t=ä. Recommendations for phototherapy during the COVID-19 pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32334056|t=ä. Teledermatology in the Wake of COVID-19: Advantages and Challenges to Continued Care in a Time of Disarray |pdf=|usr=}}
| |
| − | {{tp|p=32305443|t=ä. United States Cutaneous Lymphoma Consortium Recommendations for Treatment of Cutaneous Lymphomas During the COVID-19 Pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32305442|t=ä. Teledermatology in the Era of COVID-19: Experience of an Academic Department of Dermatology |pdf=|usr=}}
| |
| − | {{tp|p=32283242|t=ä. Recommendations on dermatologic surgery during the COVID-19 pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32283230|t=ä. Adalimumab for treatment of hidradenitis suppurativa during the COVID-19 pandemic: Safety considerations |pdf=|usr=}}
| |
| − | {{tp|p=32282439|t=ä. Orthopaedic Education During the COVID-19 Pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32324709|t=ä. The American Board of Orthopaedic Surgery Response to COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32304401|t=ä. Orthopaedic Surgical Selection and Inpatient Paradigms During the Coronavirus (COVID-19) Pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32301818|t=2020. Departmental Experience and Lessons Learned With Accelerated Introduction of Telemedicine During the COVID-19 Crisis |pdf=|usr=}}
| |
| − | {{tp|p=32287086|t=2020. Practice Management During the COVID-19 Pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32282442|t=2020. A Bioethical Perspective for Navigating Moral Dilemmas Amidst the COVID-19 Pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32282441|t=ä. Perioperative Considerations in Urgent Surgical Care of Suspected and Confirmed Coronavirus Disease 2019 Orthopaedic Patients: Operating Room Protocols and Recommendations in the Current Coronavirus Disease 2019 Pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32201335|t=2020. Cardiovascular Considerations for Patients, Health Care Workers, and Health Systems During the COVID-19 Pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32304798|t=ä. Adapting the Educational Environment for Cardiovascular Fellows-in-Training During the COVID-19 Pandemic |pdf=|usr=}}
| |
| − | {{tp|p=32304797|t=ä. Virtual Learning during the COVID-19 Pandemic: A Disruptive Technology in Graduate Medical Education |pdf=|usr=}}
| |
| − |
| |
| | ---- | | ---- |
| | | | |
| Zeile 311: |
Zeile 212: |
| | | | |
| | *'''[[misc.]]''' | | *'''[[misc.]]''' |
| − | {{tp|p=32175070|t=2020. Positive Screening for Wuhan Novel Coronavirus Infection at International Airport: What s the Final Diagnosis for Positive Cases |pdf=|usr=}}
| |
| − | {{tp|p=32372270|t=ä. Three further ways that the COVID-19 pandemic will affect health outcomes |pdf=|usr=}}
| |
| − | {{tp|p=32307030|t=ä. The fight against COVID-19: a report from the Italian trenches |pdf=|usr=}}
| |
| − | {{tp|p=32210483|t=2020. The Battle Against COVID-19: Where Do We Stand Now?|pdf=|usr=}}
| |
| − | {{tp|p=32344058|t=ä. COVID-19 diagnostic process in mainland China: the math beyond pneumonia |pdf=|usr=}}
| |
| − | {{tp|p=32348792|t=ä. Will environmental impacts of social distancing due to the pandemic caused by SARS-CoV-2 decrease allergic disease?|pdf=|usr=}}
| |
| − | {{tp|p=32330635|t=ä. Applying the ethical principles of resource allocation to drugs in limited supply during a public health crisis |pdf=|usr=}}
| |
| − | {{tp|p=32283240|t=ä. Back to the Basics: Diluted Bleach for COVID-19 |pdf=|usr=}}
| |
| − | {{tp|p=32074487|t=2020. The coronavirus (COVID-19) epidemic and patient safety |pdf=|usr=}}
| |
| − |
| |
| | | | |
| | | | |
